Finance

Beta
Lists
EU6:FRA
PDS Biotechnology Corp
€0.76
0.00%
(0.00) 1D
Jul 2, 8:00:17 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EU6...
Mkt. cap
47.84M
Avg. vol.
47.00
Volume
0.00
52-wk high
€1.22
52-wk low
€0.46
No. of employees
21
Mkt. cap
47.84M
Avg. vol.
47.00
Volume
0.00
52-wk high
€1.22
52-wk low
€0.46
No. of employees
21
News stories
From sources across the web
About PDS Biotechnology Corp
CEO-
Employees21
Founded2005
Headquarters-
SectorBiotechnology
Websitepdsbiotech.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.21M
4.58M
4.41M
3.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.41M
3.56M
2.27M
3.06M
Operating expense
7.62M
8.14M
6.67M
6.52M
Total operating expenses
7.62M
8.14M
6.67M
6.52M
Operating income
-7.62M
-8.14M
-6.67M
-6.52M
Other non operating income
-
-
-
-
EBT including unusual items
-9.43M
-9.01M
-7.56M
-7.35M
EBT excluding unusual items
-9.43M
-9.01M
-7.56M
-7.35M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.43M
-9.01M
-7.56M
-7.35M
Net profit margin
-
-
-
-
Earnings per share
-0.21
-0.19
-0.14
-0.13
Interest and investment income
333.62K
281.11K
224.66K
186.81K
Interest expense
-2.14M
-1.15M
-1.11M
-1.01M
Net interest expenses
-1.81M
-869.27K
-888.21K
-827.97K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.61M
-8.13M
-6.66M
-6.51M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer